Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000215

Pres. Diagnostics & Genom gave up 869 shares (to pay taxes)

  • Pres. Diagnostics & Genom acquired 1,691 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kelderman Kim · Pres. Diagnostics & Genom

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-08 Exercise or conversion : show line 1 in the form +1,691 1,691 D
2021-08-08 Shares withheld for taxes : show line 2 in the form −869 $481.82 $418,702 822 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-08-08 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,691 0 D
2021-08-06 Grant or award : show line 4 in the form Restricted Stock Units +1,245 1,245 D
2021-08-06 Grant or award : show line 5 in the form Stock Options (Right to Buy) +4,864 4,864 D
2021-08-06 Grant or award : show line 6 in the form Stock Options (Right to Buy) +6,486 6,486 D
Loading xslF345X03/edgar.xml…